A021703 |
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS) |
Cancer |
Gastrointestinal |
A031501 |
Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation |
Cancer |
Bladder/Urothelial |
A031803 |
Phase II Trial of Intravesical Gemcitabine and MK-3475 (pembrolizumab) in the Treatment of Patients with BCG-Unresponseve Non-Muscle Invasive Bladder Cancer |
Cancer |
Bladder |
A041702 |
Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (= 70 Years of Age) |
Cancer |
Hematology |
A061202 |
A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib VS. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy |
Cancer |
Multiple Myeloma |
AALL08B1 |
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) |
Childhood Cancers |
Leukemia |
AALL0932 |
Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) |
Childhood Cancers |
Leukemia |
AALL1231 |
A Phase lll Randomized Trial Investigating Bortezomib (NSC#681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy) |
Childhood Cancers |
Leukemia |
AALL1521 |
A Phase 2 study of the JAK1/JAK2 Inhibitor Ruxolitinib with Chemotherapy in Children with De Novo High-Risk CRLF2 Rearranged and/ or JAK Pathway-Mutant Acute Lymphoblastic Leukemia |
Childhood Cancers |
Leukemia |
Acoustic Diagnosis of Gastroesophageal Reflux Disease |
|
Baby/Child |
Reflux Disease |
ANBL1232 |
Utilizing Response-and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma |
Childhood Cancers |
Blastoma |
APEC14B1 EveryChild |
A Registry, Eligibility Screening, Biology and Outcome Study |
Childhood Cancers |
Registry |
Champion AF |
The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation. |
Heart & Vascular |
Atrial Fibrillation |
COG-AALL05B1 |
Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens |
Childhood Cancers |
Leukemia |
COG-AALL1331 |
Risk Stratified Randomized Phase lll Testing of blinatumomab (IND#117467, NCS#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) |
Childhood Cancers |
Leukemia |
COG-ACNS0332 |
Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other than Average Risk Medulloblastoma/PNET Patients |
Childhood Cancers |
Blastoma |
COG-ACNS0831 |
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years |
Childhood Cancers |
Glioma |
COG-AEWS07B1 |
A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens |
Childhood Cancers |
Sarcoma |
COG-AHEP0731 |
Treatment of Children with All Stages of Hepatoblastoma |
Childhood Cancers |
Blastoma |
COG-AHOD1331 |
A randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND # 117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents |
Childhood Cancers |
Lymphoma |
COG-ANBL00B1 |
Neuroblastoma Biology Studies |
Childhood Cancers |
Blastoma |
COG-AREN03B2 |
Renal Tumors Classification, Biology, and Banking Study |
Childhood Cancers |
Tumor |
COG: ARST1321 |
Pazopanib Neoadjuvant triao in Non-Rhabdomyosarcoma soft tissue sarcomas(PAZNTIS): A phase II/III randomized trial preoperative chemoradiation or preop radiation plus or minus Pazopanib |
Childhood Cancers |
Sarcoma |
COG:ACNS1123 |
Phase 2 trial of response based radiation therapy for patients with localized central nervous system Germ Cel Tumors |
Childhood Cancers |
Tumor |
Crest 2 |
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial IDE G130221 |
Heart & Vascular |
Cardiac Disease |
E4512 |
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib vs. Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK+) Fusion Protein (ALCHEMIST)(Sub-Study of A151216) |
Cancer |
Lung |
EA2165 |
Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer |
Cancer |
Gastrointestinal |
EA3132 |
Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing |
Cancer |
Head and Neck |
EA3161 |
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA |
Cancer |
Head and Neck |
EA5163: INSIGNA: |
A Randomized Phase III Study of First-line Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Post-progression in Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) with Immuno-biomarker SIGNature-driven Analysis |
Cancer |
Lung |